SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-003558
Filing Date
2020-03-09
Accepted
2020-03-09 06:16:30
Documents
87
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2139499
2 ex4-6.htm EX-4.6 54393
3 ex21-1.htm EX-21.1 5142
4 ex23-1.htm EX-23.1 3928
5 ex31-1.htm EX-31.1 11526
6 ex31-2.htm EX-31.2 11605
7 ex32-1.htm EX-32.1 10710
8 form10k_001.jpg GRAPHIC 30093
9 form10k_002.jpg GRAPHIC 48587
10 form10k_003.jpg GRAPHIC 15913
11 form10k_004.jpg GRAPHIC 16226
  Complete submission text file 0001493152-20-003558.txt   6596107

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE mtnb-20191231.xml EX-101.INS 762597
13 XBRL SCHEMA FILE mtnb-20191231.xsd EX-101.SCH 71590
14 XBRL CALCULATION FILE mtnb-20191231_cal.xml EX-101.CAL 80465
15 XBRL DEFINITION FILE mtnb-20191231_def.xml EX-101.DEF 262270
16 XBRL LABEL FILE mtnb-20191231_lab.xml EX-101.LAB 498270
17 XBRL PRESENTATION FILE mtnb-20191231_pre.xml EX-101.PRE 373336
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38022 | Film No.: 20696440
SIC: 2834 Pharmaceutical Preparations